Unaudited standalone and consolidated Financial Results for the quarter and half year ended on 30 September, 2025.
Announcement under Regulation 30 (LODR)-Newspaper Publication
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Titan Biotech Limited on 6ix
Earlier from Titan Biotech
- Titan Biotech Limited Press Release Nov 11 2025
- Consolidated And Standalone Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2025
- Titan Biotech Limited Press Release Nov 04 2025
- Board Meeting Intimation for Consideration And Approval Of Standalone And Consolidated Financial Results For The Quarter & Half Year Ended September 2025.
- Titan Biotech Limited Press Release Oct 09 2025
Later from Titan Biotech
- Closure of Trading Window
- Board Meeting Intimation for Proposal For Alteration In The Share Capital Of The Company By Sub-Division / Split Of Existing Equity Shares
- Titan Biotech Limited Press Release Nov 25 2025
- Board Meeting Outcome for Outcome Of Board Meeting Held On 29Th November, 2025
- Corporate Action-Intimation of Sub division / Stock Split
Follow Titan Biotech into a list and get an email when it puts out news.
Follow Titan Biotech